Searchable abstracts of presentations at key conferences in endocrinology

ea0029p103 | Adrenal cortex | ICEECE2012

GH deficiency in patients with hypoadrenalism

Mendola M. , Beltrami G. , Passeri E. , Tufano A. , Corbetta S. , Ambrosi B.

Introduction: The role of glucocorticoids in the regulation of GH secretion is not well defined. Hypercortisolism inhibits GH secretion, but also hypocortisolism is correlated with impaired GH response to dynamic tests. This study was aimed to evaluate the GH reserve after GHRH+arginine test in patients with Addison’s disease (AD) and in operated patients with Cushing’s disease (CD).Design: Twelve AD patients (6M, 6F, aged 52±3.4 years, BM...

ea0026p137 | Male reproduction | ECE2011

Hypogonadism, insulin resistance and visceral adiposity in myotonic dystrophy

Passeri E , Bugiardini E , Sansone V , Fulceri C , Costa E , Ambrosi B , Meola G , Corbetta S

Hypogonadism occurs in myotonic dystrophy (DM) type 1 and 2, a multisystemic autosomal dominant disorder. DM patients have genetically induced insulin-resistance (IR) and visceral obesity, providing a model to study the impact of metabolic disruptions on hypogonadism. We assessed hypothalamic-pituitary-gonadal function and metabolic features in 22 DM1 and 8 DM2 males (mean±S.D., 46±11years). Hypogonadism, defined as total testosterone (T)<320 ng/dl...

ea0029p300 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2

Passeri E. , Bugiardini E. , Sansone V. , Costa E. , Bandera F. , Pizzocaro A. , Meola G. , Ambrosi B. , Corbetta S.

Introduction: Myotonic dystrophy (DM) type 1 and 2 are multisystemic autosomal dominant disorders with visceral obesity, insulin resistance and hypogonadism. The prevalence of metabolic risk factors for coronary artery disease (CAD) in DM is not well defined, particularly in patients affected by DM2, a milder and clinical challenging condition.Methods: We assessed the frequency of CAD risk factors in 31 male DM1 (44±11 years) and 13 male DM2 (54&#17...

ea0029p1462 | Pituitary Clinical | ICEECE2012

Study on IGF(CA)19 gene polymorphism in adults with GH deficiency

Giavoli C , Profka E , Olgiati L , Filopanti M , Bergamaschi S , Ferrante E , Arosio M , Ambrosi B , Spada A , Beck-Peccoz P

A highly polymorphic microsatellite in the IGF1 gene promoter, composed of variable cytosine-adenine (CA) repeats (n=10–24) has been linked to IGF1 serum concentrations in normal, acromegalic and GHD subjects with conflicting results. Aim of this study was to investigate whether this polymorphism may influence the clinical and biochemical characteristics of adult patients with GHD (n=97). Moreover, the response to 12-month rhGH replacement in terms of IGF1 l...

ea0011p189 | Clinical practise and governance | ECE2006

Recombinant hGH therapy in males with organic GHD: should we trust in total testosterone levels for diagnosis of central hypogonadism?

Giavoli C , Lania AG , Ferrante E , Ermetici F , Bergamaschi S , Ronchi CL , Ambrosi B , Spada A , Beck-Peccoz P

Previous evidences have suggested that in adults with organic hypopituitarism the condition of GH deficiency (GHD) could mask the presence of other pituitary deficits. In our experience, both central hypothyroidism and hypoadrenalism were unmasked during rhGH therapy in adults with GHD due to central organic lesions. Few and conflicting information are available about the relationship among GHD, rhGH therapy and gonadal function. Aim of the present study was to investigate the...

ea0029p1030 | Male Reproduction | ICEECE2012

Leydig and sertoli cell failure in myotonic dystrophy

Passeri E. , Bugiardini E. , Sansone V. , Fulceri C. , Costa E. , Bandera F. , Borgato S. , Persani L. , Pizzocaro A. , Meola G. , Ambrosi B. , Corbetta S.

Introduction: Hypogonadism occurs in myotonic dystrophy (DM) type 1 and 2, a multisystemic autosomal dominant disorder with insulin resistance and visceral obesity. DM patients provide a model to investigate the impact of metabolic alterations on hypogonadism.Methods: We assessed Leydig and Sertoli cell functions and metabolic features in 32 DM1 (44+11 years),13 DM2 patients (54+9 years) and 32 age and BMI-matched controls.Results:...